apl. Prof. Dr. Niels Schaft

Picture of Niels Schaft


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The future of affordable cancer immunotherapy (2023) Schaft N, Dörrie J, Schuler G, Schuler-Thurner B, Sallam H, Klein S, Eisenberg G, et al. Journal article, Review article Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality. (2023) Pfister F, Dörrie J, Schaft N, Buchele V, Unterweger H, Carnell LR, Schreier P, et al. Journal article Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells (2022) Harrer DC, Schenkel C, Berking C, Herr W, Abken H, Dörrie J, Schaft N Journal article Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases (2022) Beenen AC, Sauerer T, Schaft N, Dörrie J Journal article, Review article A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma (2022) Koch E, Schaft N, Kummer M, Berking C, Schuler G, Hasumi K, Dörrie J, Schuler-Thurner B Journal article Multi-Level Computational Modeling of Anti-Cancer Dendritic Cell Vaccination Utilized to Select Molecular Targets for Therapy Optimization (2022) Lai X, Keller C, Santos Rosales G, Schaft N, Dörrie J, Vera J Journal article BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation (2021) Hoyer S, Eberlein V, Schuler G, Berking C, Heinzerling L, Schaft N, Dörrie J Journal article, Original article A chimeric il-15/il-15rα molecule expressed on nfκb-activated dendritic cells supports their capability to activate natural killer cells† (2021) Bosch NC, Martin LM, Voskens C, Berking C, Seliger B, Schuler G, Schaft N, Dörrie J Journal article T-cell responses in merkel cell carcinoma: Implications for improved immune checkpoint blockade and other therapeutic options (2021) Gehrcken L, Sauerer T, Schaft N, Dörrie J Journal article, Review article Preclinical evaluation of a combination of checkpoint blockade and dendritic cell vaccination against Merkel cell carcinoma (2021) Sauerer T, Gerer K, Hoyer S, Erdmann M, Berking C, Voll R, Schuler-Thurner B, et al. Conference contribution